NTBL
Notable Labs Inc.
NASDAQ: NTBL · HEALTHCARE · BIOTECHNOLOGY
$0.25
+0.00% today
Updated 2026-05-01
Market cap
$2.39M
P/E ratio
—
P/S ratio
7.65x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$0 – $0
Volume
2.1M
Notable Labs Inc. (NTBL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Operating cash flow | $-13.09M | $-23.38M | $-15.05M | $-11.64M | $-13.72M |
| Capital expenditures | $73000.00 | $51000.00 | $441000.00 | $41000.00 | $65000.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | — | — | $779000.00 | $581000.00 | $589000.00 |
| Free cash flow | $-13.16M | $-23.43M | $-15.49M | $-11.68M | $-13.78M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |